SCHEMBL25344845

SCHEMBL25344845

Cc1cc(Br)c(NCCCN(C)C(=O)OC(C)(C)C)c([N+](=O)[O-])c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.46
MAPT P10636 4/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
TDP1 Q9NUW8 2/20 0.46
GAA P10253 3/20 0.38
SMN1; SMN2 Q16637 2/20 0.35
ABL1 P00519 1/20 0.35
METAP2 P50579 1/20 0.35
KAT2B Q92831 2/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
HPGD P15428 2/20 0.34
LMNA P02545 1/20 0.34
ATM Q13315 1/20 0.34
KDM4E B2RXH2 2/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
CHRM2 P08172 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25342692 0.89 MAPT (0.38) ALDH1A1MAPTL3MBTL1TDP1GAA
SCHEMBL25344735 0.89 MEN1 (0.39) ALDH1A1MAPTL3MBTL1TDP1GAA
SCHEMBL31376654 0.84 CHRM2 (0.41) ALDH1A1MAPTTDP1GAASMN1; SMN2
SCHEMBL25343983 0.81 KAT2B (0.56) ALDH1A1MAPTTDP1SMN1; SMN2METAP2
SCHEMBL25344251 0.79 METAP2 (0.36) ALDH1A1MAPTGAASMN1; SMN2METAP2
SCHEMBL25346494 0.77 METAP2 (0.36) ALDH1A1MAPTSMN1; SMN2METAP2HPGD
SCHEMBL25345810 0.77 METAP2 (0.36) MAPTSMN1; SMN2METAP2KDM4ECHRM2
SCHEMBL5028697 0.76 MAPT (0.44) ALDH1A1MAPTL3MBTL1TDP1GAA
SCHEMBL25346033 0.74 MEN1 (0.52) ALDH1A1MAPTSMN1; SMN2CYP3A4CYP2C19
SCHEMBL25343679 0.74 ALDH1A1 (0.60) ALDH1A1MAPTL3MBTL1TDP1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4472739-A1 IMIDAZOLE MACROCYCLES FOR THE TREATMENT OF AUTOIMMUNE DISEASE F. Hoffmann-La Roche AG (CH) 2024-12-11 EP disclosed
WO-2023148129-A1 IMIDAZOLE MACROCYCLES FOR THE TREATMENT OF AUTOIMMUNE DISEASE F. HOFFMANN-LA ROCHE AG (CH) 2023-08-10 WO disclosed